Search research articles
Contact Us
Filters
Showing results (251-260 of 268) with videos related to
Page
of 27
Sort By:
Journal of Neuro-Oncology
|
November 22, 2018
Characterization of iPSCs derived from low grade gliomas revealed early regional chromosomal amplifications during gliomagenesis
Zhong Liu, Pulin Che, Juan J Mercado, et al.
Pharmacology & Therapeutics
|
April 29, 2022
Clinical advances in oncolytic virotherapy for pediatric brain tumors
Gelare Ghajar-Rahimi, Kyung-Don Kang, Stacie K Totsch, et al.
Journal of Neuro-Oncology
|
February 26, 2015
Prolonged treatment with bevacizumab is associated with brain atrophy: a pilot study in patients with high-grade gliomas
Asim K Bag, Hyunki Kim, Yi Gao, et al.
Cancers
|
February 15, 2022
Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy
Colin H Quinn, Andee M Beierle, Sara Claire Hutchins, et al.
Frontiers in Surgery
|
October 2, 2020
The One Health Consortium: Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Combination With a Checkpoint Inhibitor in Canine Patients With Sporadic High Grade Gliomas
M R Chambers, R Timothy Bentley, David K Crossman, et al.
Current Problems in Surgery
|
September 9, 2004
Brain metastases
Mark E Shaffrey, Melike Mut, Anthony L Asher, et al.
Theranostics
|
January 22, 2024
[<sup>89</sup>Zr]-CD8 ImmunoPET imaging of glioblastoma multiforme response to combination oncolytic viral and checkpoint inhibitor immunotherapy reveals CD8 infiltration differential changes in preclinical models
Carlos A Gallegos, Yun Lu, Jennifer C Clements, et al.
Human Gene Therapy. Clinical Development
|
March 22, 2014
Evaluation of the safety and biodistribution of M032, an attenuated herpes simplex virus type 1 expressing hIL-12, after intracerebral administration to aotus nonhuman primates
Justin C Roth, Kevin A Cassady, James J Cody, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 14, 2022
Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers
Kyung-Don Kang, Joshua D Bernstock, Stacie K Totsch, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 28, 2014
A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses
James M Markert, Shantanu N Razdan, Hui-Chien Kuo, et al.
Page
of 27
Search research articles
Search
Showing results (251-260 of 268) with videos related to
Sort By:
Page
of 27
Journal of Neuro-Oncology
|
November 22, 2018
Characterization of iPSCs derived from low grade gliomas revealed early regional chromosomal amplifications during gliomagenesis
Zhong Liu, Pulin Che, Juan J Mercado, et al.
Pharmacology & Therapeutics
|
April 29, 2022
Clinical advances in oncolytic virotherapy for pediatric brain tumors
Gelare Ghajar-Rahimi, Kyung-Don Kang, Stacie K Totsch, et al.
Journal of Neuro-Oncology
|
February 26, 2015
Prolonged treatment with bevacizumab is associated with brain atrophy: a pilot study in patients with high-grade gliomas
Asim K Bag, Hyunki Kim, Yi Gao, et al.
Cancers
|
February 15, 2022
Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy
Colin H Quinn, Andee M Beierle, Sara Claire Hutchins, et al.
Frontiers in Surgery
|
October 2, 2020
The One Health Consortium: Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Combination With a Checkpoint Inhibitor in Canine Patients With Sporadic High Grade Gliomas
M R Chambers, R Timothy Bentley, David K Crossman, et al.
Current Problems in Surgery
|
September 9, 2004
Brain metastases
Mark E Shaffrey, Melike Mut, Anthony L Asher, et al.
Theranostics
|
January 22, 2024
[<sup>89</sup>Zr]-CD8 ImmunoPET imaging of glioblastoma multiforme response to combination oncolytic viral and checkpoint inhibitor immunotherapy reveals CD8 infiltration differential changes in preclinical models
Carlos A Gallegos, Yun Lu, Jennifer C Clements, et al.
Human Gene Therapy. Clinical Development
|
March 22, 2014
Evaluation of the safety and biodistribution of M032, an attenuated herpes simplex virus type 1 expressing hIL-12, after intracerebral administration to aotus nonhuman primates
Justin C Roth, Kevin A Cassady, James J Cody, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 14, 2022
Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers
Kyung-Don Kang, Joshua D Bernstock, Stacie K Totsch, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 28, 2014
A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses
James M Markert, Shantanu N Razdan, Hui-Chien Kuo, et al.
Page
of 27